Arrowhead Pharmaceuticals Inc (ARWR)
NASDAQ · Healthcare · Biotechnology
Arrowhead Pharmaceuticals Inc is a Healthcare company with a market capitalization of $12.00B.
5-Year Price History
Latest Annual Financials · FY ending September 30, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q3 2026 | August 4, 2026 | $-1.36 | $-1.23 | -10.6% |
| Q2 2026 | May 7, 2026 | $-0.93 | $-1.11 | +16.2% |
| Q1 2026 | February 5, 2026 | $0.22 | $-0.37 | +159.5% |
| Q4 2025 | November 25, 2025 | $-0.11 | $-0.31 | +64.5% |
| Q3 2025 | August 7, 2025 | $-1.26 | $-0.94 | -34.0% |
| Q2 2025 | May 12, 2025 | $2.75 | $-0.46 | +697.8% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 9,635,297 | 6.77% | 4.9 | +14.3% |
| June 30, 2026 | 8,430,780 | 5.92% | 2.2 | -28.2% |
| June 15, 2026 | 11,738,844 | 8.24% | 8.2 | -5.3% |
| May 29, 2026 | 12,391,532 | 8.70% | 8.3 | -4.1% |
| May 15, 2026 | 12,925,632 | 9.08% | 7.0 | -0.1% |
| April 30, 2026 | 12,939,446 | 9.20% | 6.7 | +7.7% |
| April 15, 2026 | 12,012,359 | 8.54% | 7.7 | -7.6% |
| March 31, 2026 | 13,004,381 | 9.24% | 5.4 | +13.8% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Arrowhead Pharmaceuticals Inc's market cap?
As of August 13, 2026, Arrowhead Pharmaceuticals Inc (ARWR) has a market capitalization of $12.00B.
Does Arrowhead Pharmaceuticals Inc pay a dividend?
Arrowhead Pharmaceuticals Inc does not currently pay a dividend.
What sector is ARWR in?
Arrowhead Pharmaceuticals Inc is in the Healthcare sector, specifically the Biotechnology industry.
What is Arrowhead Pharmaceuticals Inc's short interest?
As of the July 15, 2026 FINRA settlement, 9,635,297 ARWR shares were sold short, or 6.77% of shares outstanding. Days to cover: 4.9. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Arrowhead Pharmaceuticals Inc's revenue?
In its latest reported fiscal year (ending September 30, 2025), Arrowhead Pharmaceuticals Inc reported revenue of $829.45M and net income of -$1.63M.
Ask your own questions about ARWR
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.